Biomarck Pharmaceuticals, Ltd.

biomarck is a biopharmaceutical company with a patented technology platform. we utilize anti-marcks peptides in order to develop and license products targeted at difficult to treat diseases with unmet needs. we are located in research triangle park, n.c. we have a worldwide patented drug platform of over 100 peptides that inhibit the phosphorylation of the marcks protein, a well published primary mediator of an inflammatory cytokine release involved in respiratory disease and cancer progression. currently, we are developing a portfolio of products utilizing marcks technology for the treatment of cancer and acute respiratory distress syndrome (ards), while exploring the potential for additional clinical indications.